Activation of CD8 T cells normalizes and correlates with the level of infectious provirus in tonsils during highly active antiretroviral therapy in early HIV-1 infection

AIDS

Volumn 13, Issue 17, 1999, Pages 2365-2376

  Dyrhol Riise, Anne Ma ^a,c   Voltersvik, Pål ^a   Olofsson, Jan ^b   Åsjö, Birgitta ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

Activation; Antiretroviral therapy; CD8; HIV 1; Lymphoid tissue; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; CD38 ANTIGEN; CD4 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN; INDINAVIR; LAMIVUDINE; ZIDOVUDINE;

ARTICLE; BIOPSY; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; PROVIRUS; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TONSIL; VIREMIA; VIRUS REPLICATION;

EID: 0032762069     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199912030-00008     Document Type: Article

References (53)

1. 1. Walker BD, Chakrabarti S, Moss B, et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 1987, 328:345-348.
2. 2. Giorgi JV, Detels R, T tell subset alterations in HIV-infected homosexual men: N1AID Multicenter AIDS cohort study. Clin Immunol Immunopathol 1989, 52:10-18.
3. 3. Brinchmann JE, Vartdal F, Thorsby E. T lymphocyte subset changes in human immunodeficiency virus infection. J Acquir Immune Defic Syndr 1989, 2:398-403.
4. 4. Lang W, Perkins H, Anderson RE, Royce R, Jewell N, Winkelstein WJ. Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J Acquir Immune Defic Syndr 1989, 2:63-69.
5. 5. Porwit A, Bottiger B, Pallesen G, Bodner A, Biberfeld P. Follicular involution in HIV lymphadenopathy. A morphometric study. APMIS 1989, 97:153-165.
6. 6. Rosenberg YJ, Zack PM, White BD, et al. Decline in the CD4 lymphocyte population in the blood of SIV-infected macaques is not reflected in lymph nodes. AIDS Res Hum Retroviruses 1993, 9:639-646.
7. + patients. Am J Pathol 1995, 146:1542-1555.
8. 8. Røsok BI, Bostad L, Voltersvik P, et al. Reduced CD4 cell counts in blood do not reflect CD4 cell depletion in tonsillar tissue in asymptomatic HIV-1 infection. AIDS 1996, 10:F35-F38.
9. 9. Levacher M, Hulstaert F, Tallet S, Ullery S, Pocidalo JJ, Bach BA. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin Exp Immunol 1992, 90:376-382.
10. 10. Kestens L, Vanham G, Gigase P, et al. Expression of activation antigens, HLA-DR and CD38, on CD8 lymphocytes during HIV-1 infection. AIDS 1992, 6:793-797.
11. + T cells in peripheral blood and lymph nodes from HlV-infected patients. Clin Exp Immunol 1995, 99:182-188.
12. + T cells in lymphoid tissues of HIV-1-infected individuals in the absence of the high-affinity IL-2 receptor. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 19:332-338.
13. 13. Bouscarat F, Levacher-Clergeot M, Dazza MC, et al. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1996, 12:17-24.
14. 14. Mahalingam M, Pozniak A, McManus TJ, Vergani D, Peakman M. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes. Clin Exp Immunol 1995, 102:481-486.
15. 15. Bofill M, Mocroft A, Lipman M, et al. Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients. AIDS 1996, 10:827-834.
16. + T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1993, 6:904-912.
17. + T lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency. J Acquir Immune Defic Syndr Hum Retrovirol 1998, 18:332-340.
18. 18. Mahalingam M, Peakman M, Davies ET, Pozniak A, McManus TJ, Vergani D. T cell activation and disease severity in HIV infection. Clin Exp Immunol 1993, 93:337-343.
19. + T cell responses associated with control of viremia. Science 1997, 278:1447-1450.
20. + T cells are detectable in most individuals with active HIV-1 infection, hut decline with prolonged viral suppression. Nat Med 1999, 5:518-525.
21. + T cell homeostasis and function in advanced HIV disease. Science 1997, 277:112-116.
22. 22. Giorgi JV, Majchrowicz MA, Johnson TD, Hultin P, Matud J, Detels R. Immunologic effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic: HIV-1 infection. AIDS 1998, 12:1833-1844.
23. 23. Bisset IR, Cone RW, Huber W, et al. Highly active antirelroviral therapy during early HIV infection reverses T cell activation and maturation abnormalities, AIDS 1998, 12:2115-2123.
24. + T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience. AIDS Res Hum Retroviruses 1998, 14:561-569.
25. + lymphocytes during antiretroviral therapy. J Infect Dis 1997, 176:1378-1382.
26. 26. Landay AL, Bethel J, Schnittman S. Phenotypic variability of lymphocyte populations in peripheral blood and lymph nodes from HIV-infected individuals and the impact of antiretroviral therapy. DATRI 003 Study Group. Division of AIDS Treatment Research Initiative. AIDS Res Hum Retroviruses 1998, 14:445-451.
27. 27. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992, 41:1-19.
28. + T cells but a high proportion of replication-competent provirus copies in asymptomatic human immunodeficiency virus type 1 infection. J Virol 1991, 65:2019-2023.
29. 29. Sundqvist VA, Albert J, Ohlsson E, Hinkula J, Fenyo EM, Wahren B. Human immunodeficiency virus type 1 p24 production and antigenic variation in tissue culture of isolates with various growth characteristics. J Med Virol 1989, 29:170-175.
30. 2+] and stimulation of protein kinase C. J Immunol 1989, 142:1834-1860.
31. 31. Ko HS, Fu SM, Winchester RJ, Yu DT, Kunkel HG. Ia determinants on stimulated human T lymphocytes. Occurrence on mitogen-and antigen-activated T cells. J Exp Med 1979, 150:246-255.
32. 32. Ullman KS, Northrop JP, Verweij CI, Crabtree GR. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annu Rev Immunol 1990, 8:421-452.
33. 33. Caruso A, Licenziati S, Corulli M, et al. Flow cytometric analysis of activation markers on stimulated T cells and their correlation with cell proliferation. Cytometry 1997, 27:71-76.
34. 34. Røsok B, Brinchmann JE, Voltersvik P, Olofsson J, Bostad L, Åsjö B. Correlates of latent and productive HIV type-1 infection in tonsillar CD4(+) T cells. Proc Natl Acad Sci USA 1997, 94:9332-9336.
35. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 1999, 5:512-517.
36. + T cell turnover. Science 1996, 274:1543-1547.
37. +T cell renewal in early HIV-1 infection: effect of highly active antiretroviral therapy. Nat Med 1998, 4:794-801.
38. 38. Reinherz EL, Kung PC, Goldstein G, Levey RH, Schlossman SF. Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T cell lineage. Proc Natl Acad Sci USA 1980, 77:1588-1592.
39. 39. Funaro A, Spagnoli GC, Ausiello CM, et al. Involvement of the multilineage CD3B molecule in a unique pathway of cell activation and proliferation. J Immunol 1990, 145:2390-2396.
40. + cell turnover. Nature 1995, 375:193-194; discussion, 198.
41. + cell turnover. Nature 1995, 375:194; discussion 198
42. - T cells. Clin Immunol Immunopathol 1995, 77:33-41.
43. 43. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995, 373:117-122.
44. 44. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
45. 45. Carcelain G, Blanc C, Leibowitch J, et al. T cell changes after combined nucleoside analogue therapy in HIV primary infection. AIDS 1999, 13:1077-1081.
46. + T cells in tonsillar tissue in HIV type 1 infection. Aids Res Hum Retroviruses 1990, 14:1635-1643.
47. 47. Katsikis PD, Wunderlich ES, Smith CA, Herzenberg LA. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J Exp Med 1995, 181:2029-2036.
48. 48. Gougeon ML, Lecoeur H, Dulioust A, et al. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J Immunol 1996, 156:3509-3520.
49. 49. Ferbas J, Daar ES, GroviT Ferbas K, et al. Rapid evolution of human immunodeficiency virus strains with increased replicative capacity during the seronegative window of primary infection. J Virol 1996, 70:7285-7289.
50. 50. Bouscarat F, Levacher M, Landman R, et al. Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy. AIDS 1998, 12:1267-1273.
51. + T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection. J Infect Dis 1998, 178:1279-1287.
52. 52. Silvestri G, Munoz C, Butini L, Bagnarelli P, Montroni M. Changes in CD8 cell subpopulations induced by antiretroviral therapy in human immunodeficiency virus infected patients. Viral Immunol 1997, 10:207-212.
53. 53. Pantaleo G, Graziosi C, Demarest JF, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993, 362:355-358.